An Evaluation of Two Schedules of VP-16 and Adriamycin in Patients with Advanced Breast Cancer
- 1 January 1980
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 37 (3) , 149-151
- https://doi.org/10.1159/000225424
Abstract
A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.Keywords
This publication has 0 references indexed in Scilit: